Valuation: hVIVO plc

Market Cap 38.13M 51M 45.55M 42.07M 71.33M 4.84B 72.51M 506M 200M 2.54B 191M 187M 8B P/E 2026 *
-5.53x
P/E 2027 * -26.4x
Enterprise Value 42.68M 57.09M 50.98M 47.09M 79.85M 5.42B 81.17M 567M 224M 2.84B 214M 210M 8.95B EV / Sales 2026 *
0.91x
EV / Sales 2027 * 0.67x
Free-Float
96.89%
Yield 2026 *
-
Yield 2027 * 1.41%
1 day+1.83%
1 week-4.31%
Current month-8.26%
1 month-17.66%
3 months-26.00%
6 months-28.39%
Current year-11.90%
1 week 5.4
Extreme 5.4
6
1 month 5.4
Extreme 5.4
6.8
Current year 5.32
Extreme 5.322
11
1 year 4.3
Extreme 4.305
11
3 years 4.3
Extreme 4.305
32
5 years 4.3
Extreme 4.305
32
10 years 4.3
Extreme 4.305
48
Manager TitleAgeSince
Chief Executive Officer 57 2022-02-23
Corporate Officer/Principal 39 2017-06-30
Director of Finance/CFO 65 2026-09-29
Director TitleAgeSince
Director/Board Member 57 2021-10-12
Chairman 59 2025-08-31
Director/Board Member - 2026-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
5/28/26 Free

Chief Financial Officer

2,289,604 0.3326%
5/28/26 Free

Chief Executive Officer

6,126,238 0.8899%
4/24/26 Sell

Founder

2,017,000 0.2930%
Change 5-day change 1-year change 3-year change Capi.($)
+1.83%-4.31%-19.57%-71.17% 51M
+2.41%+0.29%+39.41%+72.14% 64.69B
-0.15%+7.50%+11.42%+71.27% 54.78B
+0.57%+4.60%+7.71%+90.93% 53.49B
+0.37%+4.67%+26.68%+49.64% 45.98B
-1.21%+2.32%+21.50%+118.33% 42.94B
-0.37%+5.07%+243.23%+789.58% 40.08B
+0.05%+0.21%+18.06%+48.50% 33.52B
+1.19%-4.98%+26.31%-0.76% 23.97B
-0.38%+5.68%+38.39%+28.35% 23.67B
Average +0.43%+1.74%+41.31%+119.68% 38.32B
Weighted average by Cap. +0.39%+2.73%+46.01%+142.81%

Financials

2026 *2027 *
Net sales 47.02M 62.9M 56.17M 51.89M 87.98M 5.97B 89.43M 624M 247M 3.13B 236M 231M 9.86B 56.9M 76.11M 67.97M 62.79M 106M 7.22B 108M 756M 299M 3.79B 286M 280M 11.93B
Net income -6.47M -8.66M -7.73M -7.14M -12.11M -822M -12.31M -85.95M -34.03M -431M -32.49M -31.8M -1.36B -1.89M -2.53M -2.26M -2.09M -3.54M -240M -3.6M -25.11M -9.94M -126M -9.49M -9.29M -397M
Net Debt 4.55M 6.09M 5.43M 5.02M 8.51M 578M 8.65M 60.41M 23.92M 303M 22.84M 22.35M 954M 255K 341K 304K 281K 477K 32.35M 484K 3.38M 1.34M 16.95M 1.28M 1.25M 53.43M
Projected Income Statement - Annual - hVIVO plc
Logo hVIVO plc
hVIVO plc is a United Kingdom-based purpose-built, full-service international clinical development partner and engaged in human challenge trials serving biopharma companies. The Company has an end-to-end platform designed to bring important medicines to patients faster: spanning preclinical strategy, first in human studies, Phase II patient trials and specialist laboratory services, delivered through a participant database, wholly owned sites and laboratories across the UK and Germany. The Company offers integrated service lines which include consulting, clinical trials, human challenge trials, and laboratories. Its consulting provides preclinical and clinical strategy, encompassing non-clinical, clinical, CMC, pharmacokinetics, data management, biostatistics, and regulatory support to guide trial design, execution, and interpretation. The Company is also focused on Phase I/II clinical studies, particularly in dermatology and women's health.
Employees
376
Date Price Change Volume
26-10-23 GBX 5.550 +1.83% 911,008
26-10-22 GBX 5.450 -5.22% 1,869,224
26-10-21 GBX 5.750 -0.86% 1,398,017
26-10-20 GBX 5.800 0.00% 570,458
26-10-19 GBX 5.800 0.00% 434,653
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - hVIVO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.0555GBP
Average target price
0.1550GBP
Spread / Average Target
+179.28%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - hVIVO plc
  1. Stock Market
  2. Stocks
  3. VENN Stock